foroxymithine
isolated from Streptomyces nitrosporeus; structure given in first source; MW 575.57; MF C22-H37-N7-O11
Also Known As:
L-Serinamide, N2-acetyl-N5-formyl-N5-hydroxy-L-ornithyl-N-(3-(5-(3-(formylhydroxyamino)propyl)-3,6-dioxo-2-piperazinyl)propyl)-N-hydroxy-, (2S-cis)-
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Related Diseases
1. | Neoplasms (Cancer)
|
2. | Leukemia
|
3. | Breast Neoplasms (Breast Cancer)
|
4. | Bone Resorption
06/01/1993
- " Some protease inhibitors, e.g., E-64, pepstatin A, phosphoramidon, amastatin, bestatin, foroxymithine, did not influence the bone resorption, but some serine protease inhibitors such as PMSF, TLCK, TPCK and elastatinal inhibited the bone resorption at 10(-5) M, 10(-4) M, 10(-4) M, 10(-4) M, respectively. "
|
|
Related Drugs and Biologics